Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Hornick

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2006
Direct and indirect allorecognitionPhilip Hornick
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2006
Chronic rejection in the heartPhilip Hornick, Marlene Rose
The Annals of Thoracic Surgery|September 26, 2006
Tuberculous pericardial effusion after coronary artery bypass graftSampurna M Tuladhar, Mahdad Noursadeghi, Joseph J Boyle, et al.
Lancet (London, England)|March 9, 2010
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2006
Direct and indirect allorecognitionPhilip Hornick
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2006
Chronic rejection in the heartPhilip Hornick, Marlene Rose
The Annals of Thoracic Surgery|September 26, 2006
Tuberculous pericardial effusion after coronary artery bypass graftSampurna M Tuladhar, Mahdad Noursadeghi, Joseph J Boyle, et al.
Lancet (London, England)|March 9, 2010
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
Pageof 1